Results 171 to 180 of about 3,487 (207)
Some of the next articles are maybe not open access.
Validation of the International MOGAD Panel proposed criteria
Multiple Sclerosis Journal, 2023With the increased clinical interest in myelin-oligodendrocyte glycoprotein-antibody-associated disease (MOGAD), the international MOGAD panel’s proposed criteria were recently released. To evaluate its diagnostic performance, the criteria were applied to a single-center cohort.
Ki Hoon Kim +4 more
openaire +2 more sources
MOGAD: ein eigenständiges Krankheitsbild
Fortschritte der Neurologie · Psychiatrie, 2023Patienten mit Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierter Erkrankung (MOGAD) leiden häufig an schweren, bilateralen und wiederkehrenden Episoden von Retrobulbärneuritis (Optikusneuritis, ON), die zu einem neuroaxonalen Verlust der Netzhaut führen.
openaire +1 more source
Continuum
This article reviews the clinical features, MRI characteristics, diagnosis, and treatment of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
openaire +2 more sources
This article reviews the clinical features, MRI characteristics, diagnosis, and treatment of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
openaire +2 more sources
MOGAD presenting as fulminant intracranial hypertension
Journal of NeuroimmunologyMyelin oligodendrocyte glycoprotein antibody disease (MOGAD) has an expanding phenotype. We describe two cases of MOGAD with associated severe intracranial hypertension. Case 1: A 21-year-old male presented with diffuse cortical encephalitis and intracranial hypertension with both serum and CSF MOG antibody positivity.
Sai, Nagaratnam +8 more
openaire +2 more sources
Comparison of vision-related quality of life in NMOSD and MOGAD
Multiple Sclerosis and Related DisordersBackground: Aquaporin-4 antibody positive neuromyelitis spectrum disorder (AQP4+ NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) are both associated with vision loss due to optic neuritis (ON), although evidence suggests more ...
Dalia Rotstein, Liesly Lee
exaly +1 more source
Autologous hematopoietic stem cells transplantation in MOGAD
Multiple Sclerosis Journal[no abstract available]
Mariotto, Sara, Carta, Sara
openaire +3 more sources
MOGAD comes of age with new criteria
The Lancet Neurology, 2023Francesc, Graus, Josep, Dalmau
openaire +2 more sources